Skip to content
10-Q

Quarterly Report

GILEAD SCIENCES, INC. GILD

0000882095-25-000012

← back to feed
Filed
May 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 30, 2025 1.24B sh
Long Term Debt Q1 2025 · Mar 31, 2025 $22.15B
Long Term Debt Q1 2025 · Dec 31, 2024 $24.9B
Short Term Debt Q1 2025 · Mar 31, 2025 $2.81B
Short Term Debt Q1 2025 · Dec 31, 2024 $1.82B
Stockholders Equity Q1 2025 · Mar 31, 2025 $19.16B
Stockholders Equity Q1 2025 · Dec 31, 2024 $19.33B
Current Liabilities Q1 2025 · Mar 31, 2025 $12.34B
Current Liabilities Q1 2025 · Dec 31, 2024 $12B
Current Assets Q1 2025 · Mar 31, 2025 $16.9B
Current Assets Q1 2025 · Dec 31, 2024 $19.17B
Total Assets Q1 2025 · Mar 31, 2025 $56.43B
Total Assets Q1 2025 · Dec 31, 2024 $59B
Shares Diluted Q1 2025 · Mar 31, 2024 1.25B sh
Stock Repurchased Q1 2025 · Mar 31, 2024 $400M
Dividends Paid Q1 2025 · Mar 31, 2024 $990M
Capex Q1 2025 · Mar 31, 2024 $105M
Operating Cash Flow Q1 2025 · Mar 31, 2024 $2.22B
Eps Diluted Q1 2025 · Mar 31, 2024 −$3.34
Eps Basic Q1 2025 · Mar 31, 2024 −$3.34
Sga Expense Q1 2025 · Mar 31, 2024 $1.38B
Net Income Q1 2025 · Mar 31, 2024 −$4.17B
Operating Income Q1 2025 · Mar 31, 2024 −$4.32B
Cost Of Revenue Q1 2025 · Mar 31, 2024 $1.55B
Revenue Q1 2025 · Mar 31, 2024 $6.69B